fingolimod hydrochloride has been researched along with Complications of Diabetes Mellitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, A; Gong, K; Li, Q; Lu, X; Ma, ZA; Song, W; Wang, X; Wang, YJ; Xiao, YF; Xu, L; Yu, G; Zang, M | 1 |
| Cao, F; Fan, L; Gao, H; Tao, L; Wang, H; Wei, L; Yin, Z; Zhang, R | 1 |
1 trial(s) available for fingolimod hydrochloride and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Immunomodulator FTY720 improves glucose homeostasis and diabetic complications by rejuvenation of β-cell function in nonhuman primate model of diabetes.
Topics: Animals; Diabetes Complications; Diabetes Mellitus, Type 2; Fingolimod Hydrochloride; Glucose; Glycated Hemoglobin; Homeostasis; Immunologic Factors; Insulin; Male; Primates; Rejuvenation | 2022 |
1 other study(ies) available for fingolimod hydrochloride and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
FTY720 protects cardiac microvessels of diabetes: a critical role of S1P1/3 in diabetic heart disease.
Topics: Apoptosis; Base Sequence; Blotting, Western; Coronary Vessels; Diabetes Complications; DNA Primers; Fingolimod Hydrochloride; Heart Diseases; Humans; In Situ Nick-End Labeling; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Microvessels; Neovascularization, Pathologic; Propylene Glycols; Receptors, Lysosphingolipid; Reverse Transcriptase Polymerase Chain Reaction; Sphingosine | 2012 |